14-551: Biotechnology and Biological Sciences Research Council ( BBSRC ), part of UK Research and Innovation , is a non-departmental public body (NDPB), and is the largest UK public funder of non-medical bioscience. It predominantly funds scientific research institutes and university research departments in the UK . Receiving its funding through the science budget of the Department for Science, Innovation and Technology , BBSRC's mission
28-669: Is developing a new knowledge exchange framework, KEF. Mark Walport Sir Mark Jeremy Walport (born 25 January 1953 ) is an English medical scientist and was the Government Chief Scientific Adviser in the United Kingdom from 2013 to 2017 and Chief Executive of UK Research and Innovation (UKRI) from 2017 to 2020. In 2023 he became the Foreign Secretary of The Royal Society (jointly with Alison Noble ). Walport
42-531: Is managed by the BBSRC Council consisting of a chair (Professor Martin Humphries ), an executive chair (Professor Guy Poppy) and from ten to eighteen representatives from UK universities, government and industry. The council approves policies, strategy, budgets and major funding. A research panel provides expert advice which BBSRC Council draws upon in making decisions. The purpose of the research panel
56-537: Is the son of a general practitioner and was born in London. He was educated at St Paul's School, London , studied medicine at Clare College, Cambridge , and completed his clinical training at Hammersmith , Guy's and Brompton Hospitals in London. He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge . Previously Walport
70-478: Is to "promote and support, by any means, high-quality basic, strategic and applied research and related postgraduate training relating to the understanding and exploitation of biological systems". BBSRC's head office is at Polaris House in Swindon - the same building as the other councils of UK Research and Innovation , AHRC EPSRC , ESRC , Innovate UK , MRC , NERC , Research England and STFC , as well as
84-552: Is to advise on: In addition to the council and the research panel, BBSRC has a series of other internal bodies for specific purposes. The council strategically funds eight research institutes in the UK , and a number of centres. They have strong links with business, industry and the wider community, and support policy development. The institutes' research underpins key sectors of the UK economy such as agriculture, bioenergy, biotechnology, food and drink and pharmaceuticals. In addition,
98-548: Is to foster research and development within the United Kingdom and create a positive "impact"—"push the frontiers of human knowledge and understanding", "deliver economic impact", and "create social and cultural impact". The first Chief Executive Officer of UKRI was the immunologist Professor Sir Mark Walport . He was succeeded in June 2020 by plant biologist Professor Dame Ottoline Leyser . There are nine bodies in UKRI, comprising
112-635: The UKSA . Funded by Government, BBSRC invested over £498 million in bioscience in 2017–18. BBSRC also manages the joint Research Councils' Office in Brussels – the UK Research Office (UKRO). BBSRC was created in 1994, merging the former Agricultural and Food Research Council (AFRC) and taking over the biological science activities of the former Science and Engineering Research Council (SERC). Chairs Chief executives Executive chairs BBSRC
126-548: The immunology of systemic LE and the role of complement and of defective apoptosis in its pathogenesis ; and, as a general candidate, for his achievements as head of medicine at the Hammersmith Campus of Imperial College and since 2003 as Director of the Wellcome Trust. In the latter role he has provided national and international leadership at the highest level on biomedical research and policy issues and
140-487: The institutes maintain unique research facilities of national importance. Other research institutes have merged with each other or with local universities. Previous BBSRC (or AFRC) sponsored institutes include: UK Research and Innovation UK Research and Innovation ( UKRI ) is a non-departmental public body of the Government of the United Kingdom that directs research and innovation funding, funded through
154-703: The science budget of the Department for Science, Innovation and Technology . Established on 1 April 2018 by the Higher Education and Research Act 2017 , UKRI brought nine organisations into one unified body. UKRI was created following a report by Sir Paul Nurse , the President of the Royal Society , who recommended the merger in order to increase integrative cross-disciplinary research. Working in partnership with universities, research organisations, businesses, charities, and government, its mission
SECTION 10
#1732772562392168-600: The seven research councils formerly organised under Research Councils UK and two additional bodies, Innovate UK and Research England . Innovate UK (formerly the Technology Strategy Board) was an Arms Length Body of the Department of Trade and Industry , while Research England succeeded the former Higher Education Funding Council for England . Research England is responsible for the Research Excellence Framework , or REF, and
182-538: Was Director of the Wellcome Trust from 2003 to 2013. Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at Imperial College London , where he led a research team that focused on the immunology and genetics of rheumatic diseases . Walport was the eleventh Government Chief Scientific Adviser from 2013 to 2017, succeeding Sir John Beddington . It
196-604: Was announced in February 2017 that Mark Walport is now Chief Executive of UK Research and Innovation (UKRI) . Walport was knighted in the 2009 New Year Honours list for services to medical research. He was elected an Honorary Fellow of the Royal Society of Edinburgh (FRSE) in 2017 and a Fellow of the Royal Society (FRS) in 2011. His nomination for the Royal Society reads: Mark Walport has an overwhelming case for election both for his earlier scientific work on
#391608